ROCHE GS | 309.65 / +0.81% |
News
- GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Recently Announced Tender Offer for GNMK and Encourages Investors to Contact the Firm
04/01/2021 / 01:50 - GlobeNewswire - Roche: Antibody cocktail 70% effective in preventing COVID deaths
03/23/2021 / 08:16 - TeleTrader - GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GNMK and Encourages Investors to Contact the Firm
03/15/2021 / 18:57 - GlobeNewswire - Roche to acquire GenMark Diagnostics for $1.8 billion
03/15/2021 / 08:07 - TeleTrader - FDA: Roche's COVID tests can produce false positive results
03/12/2021 / 18:00 - TeleTrader - Trial of Roche's drug plus remdesivir didn't meet its endpoints
03/11/2021 / 08:51 - TeleTrader - Roche hopes to build pill against COVID by year end - CEO
03/09/2021 / 14:00 - TeleTrader - Roche's sales up 1% to 14.3B Swiss francs in Q4
02/04/2021 / 07:17 - TeleTrader - Moderna to use Roche antibody test in COVID vaccine trial
12/09/2020 / 07:13 - TeleTrader - Roche to launch antigen COVID test by end of 2020
10/13/2020 / 09:23 - TeleTrader - Roche to look for approval of COVID-19 test in Japan
09/11/2020 / 11:28 - TeleTrader - Trump: Big pharma coming to WH to talk prices
07/24/2020 / 22:13 - TeleTrader - Roche: Demand on record highs amid COVID-19
07/23/2020 / 10:40 - TeleTrader - Roche buys US DNA sequencing startup
05/22/2020 / 09:10 - TeleTrader - UK signs contract with Roche to supply over 10M tests - Hancock
05/21/2020 / 18:21 - TeleTrader